The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients

BACKGROUND: Recent randomized trials have not found that polymyxin B hemoperfusion (PMX-HP) improves outcomes for patients with sepsis. However, it remains unclear whether the therapy could provide benefit for highly selected patients. Monocyte human leukocyte antigen (mHLA-DR) expression, a critica...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Crit Care
Prif Awduron: Srisawat, Nattachai, Tungsanga, Somkanya, Lumlertgul, Nuttha, Komaenthammasophon, Chalermchai, Peerapornratana, Sadudee, Thamrongsat, Nicha, Tiranathanagul, Khajohn, Praditpornsilpa, Kearkiat, Eiam-Ong, Somchai, Tungsanga, Kriang, Kellum, John A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2018
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204024/
https://ncbi.nlm.nih.gov/pubmed/30367647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-018-2077-y
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg